Clinical Trial Update: Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis [NA]

View source ↗

Summary

A clinical trial registry entry for nalfurafine hydrochloride orally disintegrating tablet to treat moderate-to-severe pruritus in patients on peritoneal dialys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Pruritus

Drugs mentioned

• Nalfurafine hydrochloride ODT (nalfurafine hydrochloride)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Adverse Event, Peritoneal Dialysis | NA | Status: RECRUITING